This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on October 27, 2022.
Return to the list of Patented Medicine Litigation page.
Escitalopram
CIPRALEX, CIPRALEX MELTZ – Lundbeck Canada Inc. (NOC Search)
Patents:
- 1094087: APOTEX
- 1336452: APOTEX
- 1339452: RATIOPHARM, COBALT, SANDOZ, PHARMASCIENCE, MYLAN, TEVA, APOTEX, GENPHARM
- 2373757: ACCORD HEALTHCARE, RANBAXY
- 2612827: ACTAVIS
ACCORD HEALTHCARE
- PM(NOC) – T-1819-14
ACTAVIS
- PM(NOC) – T-1611-15
APOTEX
- Appeal – A-128-13 – A-129-09 – A-300-12 (2013 FCA 46) – A-421-13
- Infringement – T-1407-09 (2010 FC 807, 2012 FC 414, 2013 FC 192, 2013 FC 1188)
- PM(NOC) – A-336-08 (2008 FCA 265, 2009 FCA 130) – T-991-07 (2008 FC 787)
COBALT
- Other – T-1395-07 (2014 FC 1049)
- Appeal – A-139-09
GENPHARM
- PM(NOC) – T-372-07 (2007 FC 412, 2009 FC 146)
MYLAN
- Appeal – A-135-09 (2010 FCA 320)
PHARMASCIENCE
- PM(NOC) – T-1708-08
RANBAXY
- PM(NOC) – T-59-12
RATIOPHARM
- PM(NOC) – T-1599-08
SANDOZ
- PM(NOC) – T-122-09
TEVA
- PM(NOC) – T-1142-08
Return to the Patented Medicine Litigation page.